8 Coupons
-
Special Offer
-
30% off
advertisement
.
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.the youngest claimant was aged 20, and the eldest aged 89, while the average policy duration at claim stage was 10 years. .
register